+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07002112

Phase 1 Study of Single-Dose CD19CD20 Dual-Target CAR-T Lentiviral Therapy for Adults with Relapsed or Refractory B-cell Malignancies

Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2026-05-14

30

Participants Needed

6

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and effectiveness of a new CD19CD20 Dual-Target in vivo CAR-T Lentiviral product in adults aged 18 years or older with relapsed or refractory B-cell malignancies. This Phase I clinical trial focuses on patients with certain blood cancers who have not responded to previous treatments or whose disease has returned. The study aims to understand how well this novel cell therapy works and its safety profile. Participants will receive a single infusion of the CD19CD20 Dual-Target in vivo CAR-T Lentiviral product. Before the infusion, some patients may receive bridging therapy if needed to control their disease. The study includes several phases screening to determine eligibility, possible bridging therapy, treatment with the CAR-T product, and a follow-up period lasting up to about two years to monitor responses and side effects. During the study, participants will be closely monitored through clinical evaluations and laboratory tests to assess tumor response and the therapys effects on the body. Key measures include tracking adverse events, drug levels in blood and bone marrow, and immune response. Researchers will also evaluate overall survival, progression-free survival, time to response, and duration of response. The total study participation spans approximately two years after treatment, with safety and efficacy assessments throughout this period.

CONDITIONS

Brief Title

The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies

Research Team

F

FAN Lei

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here